RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 66 filers reported holding RA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $34,000 | -98.8% | 700 | -98.8% | 0.00% | -100.0% |
| Q4 2019 | $2,814,000 | +16452.9% | 59,962 | +8466.0% | 0.00% | – |
| Q3 2019 | $17,000 | -19.0% | 700 | -0.7% | 0.00% | – |
| Q2 2019 | $21,000 | +31.2% | 705 | +0.7% | 0.00% | – |
| Q1 2019 | $16,000 | +23.1% | 700 | -0.4% | 0.00% | – |
| Q4 2018 | $13,000 | -18.8% | 703 | -18.4% | 0.00% | – |
| Q3 2018 | $16,000 | – | 862 | +5287.5% | 0.00% | – |
| Q2 2018 | $0 | – | 16 | +128.6% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 7 | -99.3% | 0.00% | – |
| Q3 2017 | $16,000 | +220.0% | 1,069 | +381.5% | 0.00% | – |
| Q1 2017 | $5,000 | -37.5% | 222 | -55.2% | 0.00% | – |
| Q4 2016 | $8,000 | – | 495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 6,138,797 | $288,094,000 | 13.62% |
| RA Capital Management | 4,858,260 | $227,998,000 | 6.91% |
| HAVENS ADVISORS LLC | 116,000 | $5,444,000 | 4.77% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,115,600 | $99,286,000 | 3.16% |
| SYQUANT CAPITAL SAS | 129,690 | $6,086,000 | 3.13% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 391,758 | $18,386,000 | 3.02% |
| Kellner Capital, LLC | 91,100 | $4,275,000 | 2.71% |
| Telemetry Investments, L.L.C. | 17,100 | $803,000 | 2.68% |
| Versor Investments LP | 1,002,649 | $47,054,000 | 2.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,519,718 | $71,320,000 | 2.28% |